^Hagiwara, H.; Sunada, Y. (). „Mechanism of taxane neurotoxicity”. Breast Cancer (Tokyo, Japan). 11 (1): 82–85. PMID14718798.
^Rowinsky, MD, Eric K. (februarie 1997). „THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS”. Annual Review of Medicine. 48 (1): 353–374. doi:10.1146/annurev.med.48.1.353. PMID9046968.